Trinity Capital's Strategic Investment of $130 Million Supports Candel Therapeutics' Cancer Treatments Trinity Capital Inc. has announced a $130 million investment in Candel Therapeutics to enhance the development of innovative viral immunotherapies for cancer.

Trinity Capital's Strategic Investment of $130 Million Supports Candel Therapeutics' Cancer Treatments #USA #Cancer_Treatment #Phoenix #Trinity_Capital #Candel_Therapeutics